Clinical Trial Update: Metformin Treatment on Cognitive Impairment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating metformin for cognitive impairment in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Central South University | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED